NPS

0.135

(%)

TAKE-OVERS & MERGERS (PARAGRAPH/RULE 9.19 (47A))

NOVA PHARMA SOLUTIONS BERHAD

Type Announcement
Subject TAKE-OVERS & MERGERS (PARAGRAPH/RULE 9.19 (47A))
Description
NOVA PHARMA SOLUTIONS BERHAD ("NPS" OR "THE COMPANY")

UNCONDITIONAL MANDATORY TAKE-OVER OFFER FROM KENANGA INVESTMENT BANK BERHAD ("KENANGA IB") ON BEHALF OF SOUTHERN SCORE BUILDERS BERHAD ("SSBB" OR "THE OFFEROR") TO ACQUIRE ALL THE REMAINING ORDINARY SHARES IN NPS NOT ALREADY HELD BY THE OFFEROR AND THE PERSONS ACTING IN CONCERT WITH IT ("OFFER SHARE(S)") FOR A CASH CONSIDERATION OF RM0.37 PER OFFER SHARE ("OFFER")

 

Reference is made to NPS’ announcements dated 22 December 2025, 23 December 2025, 29 December 2025, 12 January 2026, 22 January 2026, 23 January 2026, 29 January 2026, 3 February 2026 and 27 February 2026 (“Announcements”). Unless otherwise stated, all abbreviations used herein shall have the same meaning as defined in the Announcements.

 

We wish to announce that the Offeror had on 10 March 2026, despatched the notice to Dissenting Shareholders, notifying them of the Offeror’s intention to compulsorily acquire any remaining Offer Shares held by the Dissenting Shareholders for which acceptances have not been received pursuant to subsection 222(1) of the CMSA (“Compulsory Acquisition Notice”).

 

Subject to the provisions of the CMSA, the Offeror shall be registered as the holder of the remaining Offer Shares not already owned by the Offeror and its PACs:

 

(i)         after the expiration of 1 month from the date of the Compulsory Acquisition Notice; or

 

(ii)        if applicable, after 14 days from the date of posting of the statement of the names and addresses of all other Dissenting Shareholders, to the Dissenting Shareholder upon his/her request,

 

whichever is later.

 

The compulsory acquisition exercise will be on the same terms and conditions as set out in the Offer.

 

Please refer to the attached Compulsory Acquisition Notice for further information.

 

 

This announcement is dated 10 March 2026.

 




Please refer attachment below.



Announcement Info

Company Name NOVA PHARMA SOLUTIONS BERHAD
Stock Name NPS
Date Announced 10 Mar 2026
Category General Announcement for PLC
Reference Number GA1-10032026-00062